Views
2 years ago

Healthcare

  • Text
  • Noerr
  • Germany
  • Awards
  • Solutions
  • Liability
  • Healthcare
  • Brussels
  • Firms
  • Alicante
  • Munich

NOERR_HEALTHCARE

NOERR_HEALTHCARE 4

HEALTHCARE_NOERR New technical, genetic and medical opportunities and methods are driving the development of healthcare. From technology-based diagnostics to tailored 3D-printed implants – progress and digital transformation are multiplying the possibilities for dealing with disease. This opens up growth opportunities, provided that companies master the related challenges. Researching and developing medical products or therapeutic procedures is capital-intensive and time-consuming. Sometimes decades can pass between the basic research or the first preclinical study and approval. Protecting the intellectual property which arises and eventually realising the added value only happens with strong partners and a superior strategy. Not to forget: Virtually no market is as strictly regulated as the healthcare sector. Under the German Pharmaceutical Market Reorganisation Act, new products must not only prove they are effective and thus literally worth their price, but developers, manufacturers, retailers and users are also subject to ever-stricter compliance requirements and transparency obligations. Product liability risk is also a challenge for companies. Even the suspicion of an error can be reason enough for a product recall. So it is all the more important to have legal advice which focuses on the interests of companies. 5 / YOUR CHALLENGES

English

Whitepaper: EU Digital Single Market Strategy
Public M&A Report H1/2018
Legal issues of digitalisation in Europe
Studie: M&A Treiber für die digitale Transformation